Extracellular matrix and left atrial remodeling in patients with ischemic chronic heart failure and renal dysfunction
DOI:
https://doi.org/10.14739/2310-1210.2016.1.63870Keywords:
Heart Failure, Left Atrium, Extracellular Matrix, KidneyAbstract
Remodeling occurs in the structural components of the myocardium – extracellular matrix, which is constantly synthesized, degraded and is an integral part of most pathological conditions of the heart.
Aim. To identify the characteristics of remodeling extracellular matrix and left atrial in patients with ischemic chronic heart failure and renal dysfunction.
Methods and results. Collagen metabolism markers (MMP-9, TIMP-1, РІСР), cystatin C activity were studied in 336 patients with ischemic chronic heart failure using ELISA method. Structural and functional parameters of the heart were detected by echocardiography. It was established that the moderate renal dysfunction presence in ischemic chronic heart failure is associated with age, history of atrial fibrillation, accompanied by the increasing of NT-proBNP, cystatin C, MMP-9, reduced TIMP-1 and is characterized by structural remodeling of the left atrium with increased systolic pressure in the pulmonary artery, the deterioration of systolic and diastolic function.
Conclusion.
Left atrium pathologic remodeling in patient with CHF is important part of the structural and functional changes of the heart, that is accompanied with extracellular matrix balance disturbances and renal functioning decrease.
References
Berk, B., Fujiwara, K., & Lehoux, S. (2007). ECM remodeling in hypertensive heart disease. Journal Of Clinical Investigation, 117(3), 568–575. doi: 10.1172/JCI31044.
Hamer, R., & Nahas, A M. El. (2006). The burden of chronic kidney disease. BMJ, 332(7541), 563–564. doi: 10.1136/bmj.332.7541.563.
Hundae, A., & McCullough, P. (2014). Cardiac and Renal Fibrosis in Chronic Cardiorenal Syndromes. Nephron Clinical Practice, 127(1–4), 106–112. doi: 10.1159/000363705
Voronkov, L. H., Amosova, K. M., Bahrii, A. E., Dziak, H. V., Diadyk, O. I., Zharinov, O. Y., et al. (2012). Rekomendatsii z diahnostyky ta likuvannia khronichnoi sertsevoi nedostatnosti [Guidelines for the diagnosis and treatment of chronic heart failure]. Sertseva nedostatnist, 3, 60–96 [in Ukrainian].
(2013). Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International Supplements, 3, 1–150.
Chronic Kidney Disease in the NHANES Population. (2010). American Journal Of Kidney Diseases, 55(1), S35–S48. http://dx.doi.org/10.1053/j.ajkd.2009.10.015.
Bagshaw, S., Cruz, D., Aspromonte, N., Daliento, L., Ronco, F., Sheinfeld, G. et al. (2010). Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrology Dialysis Transplantation, 25(5), 1406–1416. doi: 10.1093/ndt/gfq066.
Kottgen, A., Russell, S., Loehr, L., Crainiceanu, C., Rosamond, W., Chang, P. et al. (2007). Reduced Kidney Function as a Risk Factor for Incident Heart Failure: The Atherosclerosis Risk in Communities (ARIC) Study. Journal Of The American Society Of Nephrology, 18(4), 1307–1315. doi: 10.1681/ASN.2007020225.
Herzog, C., Asinger, R., Berger, A., Charytan, D., Díez, J., Hart, R. et al. (2011). Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int, 80(6), 572–586. doi: 10.1038/ki.2011.223.
Cerasola, G., Nardi, E., Palermo, A., Mulè, G., & Cottone, S. (2011). Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review. JN, 24(1), 1–10.
Zoccali, C., Benedetto, F., Tripepi, G., & Mallamaci, F. (2004). HYPERTENSION IN HEMODIALYSIS PATIENTS: Cardiac Consequences of Hypertension in Hemodialysis Patients. Seminars In Dialysis, 17(4), 299–303. doi: 10.1111/j.0894-0959.2004.17331.x.
López, B., González, A., Hermida, N., Laviades, C., & Díez, J. (2008). Myocardial fibrosis in chronic kidney disease: potential benefits of torasemide. Kidney Int, 74, S19–S23. doi: 10.1038/ki.2008.512.
Amann, K., Buzello, M., Simonaviciene, A., Miltenberger-Miltenyi, G., Koch, A., Nabokov, A. et al. (2000). Capillary/myocyte mismatch in the heart in renal failure--a role for erythropoietin? Nephrology Dialysis Transplantation, 15(7), 964–969. doi: 10.1093/ndt/15.7.964.
Ritz, E. (2009). Left ventricular hypertrophy in renal disease: beyond preload and afterload. Kidney Int, 75(8), 771–773. doi: 10.1038/ki.2009.35.
Glassock, R., Pecoits-Filho, R., & Barberato, S. (2009). Left Ventricular Mass in Chronic Kidney Disease and ESRD. Clinical Journal Of The American Society Of Nephrology, 1, S79–S91. doi: 10.2215/CJN.04860709.
Kalogeropoulos, A., Tsiodras, S., Rigopoulos, A., Sakadakis, E., Triantafyllis, A., Kremastinos, D., & Rizos, I. (2011). Novel association patterns of cardiac remodeling markers in patients with essential hypertension and atrial fibrillation. BMC Cardiovasc Disord, 11(1), 77. doi: 10.1186/1471-2261-11-77.
Staszewsky, L., Wong, M., Masson, S., Raimondi, E., Gramenzi, S., & Proietti, G. et al. (2011). Left Atrial Remodeling and Response to Valsartan in the Prevention of Recurrent Atrial Fibrillation: The GISSI-AF Echocardiographic Substudy. Circulation: Cardiovascular Imaging, 4(6), 721–728. doi: 10.1161/CIRCIMAGING.111.965954.
Goktekin, O. (2014). Novel fibro-inflammation markers in assessing left atrial remodeling in non-valvular atrial fibrillation. Med Sci Monit, 20, 463–470. doi: 10.12659/MSM.890635.
Wang, L., Wang, J., Wang, Y., Fu, Q., Lei, Y. H., Nie, Z. Y., Qiu, J., & Bao, T. Y. (2014). Protective effect of exogenous matrix metalloproteinase 9 on chronic renal failure. Experimental And Therapeutic Medicine, 7, 329–334. doi: 103892/etm.2013.1409.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
